NCT00003810View on ClinicalTrials.gov

Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

August 11, 1999

Primary Completion Date

May 31, 2002

Conditions
Pancreatic Cancer
Interventions
DRUG

docetaxel

DRUG

gemcitabine hydrochloride

Trial Locations (10)

21204

Greater Baltimore Medical Center and Cancer Center, Baltimore

21287

Johns Hopkins Oncology Center, Baltimore

37212

Veterans Affairs Medical Center - Nashville, Nashville

53705

Veterans Affairs Medical Center - Madison, Madison

53792

University of Wisconsin Comprehensive Cancer Center, Madison

68131

CCOP - Missouri Valley Cancer Consortium, Omaha

46202-5265

Indiana University Cancer Center, Indianapolis

02111

New England Medical Center Hospital, Boston

02215

Beth Israel Deaconess Medical Center, Boston

37232-6838

Vanderbilt Cancer Center, Nashville

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00003810 - Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas | Biotech Hunter | Biotech Hunter